Natáur

Natáur is a biotechnology company dedicated to the research and development of L-ergothioneine, a unique dietary amino acid with potent cytoprotective properties. The company focuses on the SLC22A4 (OCTN1) transporter, which specifically facilitates the uptake of ergothioneine into cells, particularly under conditions of oxidative stress. Natáur's mission is to address ergothioneine deficiency and its links to age-related diseases such as neurodegeneration and cardiovascular decline. They provide high-purity, sustainably produced ergothioneine for use in clinical research, medical foods, and potentially pharmaceutical applications. The company was co-founded by renowned scientist Dr. Bruce Ames to translate decades of research into accessible health solutions for longevity. Their lead programs target cognitive decline and healthy aging through the optimization of cellular ergothioneine levels.